litlas
ログインアカウント作成

Xianjun Yu

2007–2025 年に発表

287
論文数
27,151
被引用数
86
h 指数
267
i10 指数

被引用数

Xianjun Yu の年別被引用数1964 年: 被引用 1 件1982 年: 被引用 1 件1989 年: 被引用 1 件1995 年: 被引用 1 件2004 年: 被引用 1 件2006 年: 被引用 1 件2008 年: 被引用 4 件2009 年: 被引用 13 件2010 年: 被引用 27 件2011 年: 被引用 44 件2012 年: 被引用 37 件2013 年: 被引用 60 件2014 年: 被引用 75 件2015 年: 被引用 60 件2016 年: 被引用 82 件2017 年: 被引用 111 件2018 年: 被引用 121 件2019 年: 被引用 535 件2020 年: 被引用 882 件2021 年: 被引用 1,304 件2022 年: 被引用 1,452 件2023 年: 被引用 1,396 件2024 年: 被引用 2,642 件2025 年: 被引用 1,533 件2026 年: 被引用 37 件1965〜1981 年は被引用が無いため表示していません1983〜1988 年は被引用が無いため表示していません1990〜1994 年は被引用が無いため表示していません1996〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 5,266 件、この内訳の 40.5%アメリカ合衆国: 引用元論文 1,976 件、この内訳の 15.2%イタリア: 引用元論文 459 件、この内訳の 3.5%ドイツ: 引用元論文 423 件、この内訳の 3.2%イギリス: 引用元論文 399 件、この内訳の 3.1%インド: 引用元論文 315 件、この内訳の 2.4%日本: 引用元論文 302 件、この内訳の 2.3%韓国: 引用元論文 281 件、この内訳の 2.2%フランス: 引用元論文 226 件、この内訳の 1.7%オーストラリア: 引用元論文 221 件、この内訳の 1.7%スペイン: 引用元論文 202 件、この内訳の 1.6%イラン: 引用元論文 195 件、この内訳の 1.5%
0%40.5%その他 21.1%

機関

分野

  • Medicine44.5%
  • Biochemistry, Genetics and Molecular Biology39.9%
  • Immunology and Microbiology8.3%
  • Engineering2.4%
  • Materials Science1.3%
  • Nursing0.8%
  • その他2.8%

トピック

  • Pancreatic and Hepatic Oncology Research4.9%
  • Ferroptosis and cancer prognosis4.4%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Immune cells in cancer3%
  • RNA modifications and cancer2.9%
  • Cancer-related molecular mechanisms research2.5%
  • その他79.1%

共著者

全論文

検索で開く
  1. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

    著者: Xiaoqi Mao, Jin Xu, Wei Wang, Chen Liang, Jie Hua, Jiang Liu, Bo Zhang, Qingcai Meng, Xianjun Yu, Si Shi - Molecular Cancer 2021 被引用: 2,300

  2. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

    著者: Xuhui Tong, Rong Tang, Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Xianjun Yu, Si Shi - Journal of Hematology & Oncology 2022 被引用: 834

  3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

    著者: Rong Tang, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Si Shi - Journal of Hematology & Oncology 2020 被引用: 1,359

  4. The role of necroptosis in cancer biology and therapy

    著者: Yitao Gong, Zhiyao Fan, Guopei Luo, Chao Yang, Qiuyi Huang, Kun Fan, Cheng He, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu - Molecular Cancer 2019 被引用: 1,080

  5. Applications of single-cell sequencing in cancer research: progress and perspectives

    著者: Yalan Lei, Rong Tang, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Xianjun Yu, Si Shi - Journal of Hematology & Oncology 2021 被引用: 602

  6. The role of collagen in cancer: from bench to bedside

    著者: Shuaishuai Xu, Huaxiang Xu, Wenquan Wang, Shuo Li, Hao Li, Tianjiao Li, Wuhu Zhang, Xianjun Yu, Liang Liu - Journal of Translational Medicine 2019 被引用: 755

  7. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

    著者: Jing Yang, Jin Xu, Wei Wang, Bo Zhang, Xianjun Yu, Si Shi - Signal Transduction and Targeted Therapy 2023 被引用: 352

  8. Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives

    著者: Zengli Fang, Qingcai Meng, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Yingjun Zhao, Xianjun Yu, Si Shi - Cancer Communications 2022 被引用: 262

  9. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter

    著者: Guopei Luo, Kaizhou Jin, Shengming Deng, Cheng He, Zhiyao Fan, Yitao Gong, Yunzhen Qian, Qiuyi Huang, Quanxing Ni, Chen Liu, Xianjun Yu - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020 被引用: 427

  10. Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer

    著者: Ting Wang, Ye Zeng, Zheng Li, Desheng Jing, Guixiong Fan, Mengqi Liu, Qifeng Zhuo, Shunrong Ji, Xianjun Yu, Xiaowu Xu, Yi Qin - Cell Proliferation 2023 被引用: 174

  11. Liquid–liquid phase separation in tumor biology

    著者: Xuhui Tong, Rong Tang, Jin Xu, Wei Wang, Yingjun Zhao, Xianjun Yu, Si Shi - Signal Transduction and Targeted Therapy 2022 被引用: 254

  12. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

    著者: W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xianjun Yu, Ya Zhang, Mei Liu, Andrew F. Walls, Alex Bousamra, Maheshwari Ramineni, Bruno V. Sinn, Kelly K. Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy L. Moulder, Lajos Pusztai, Christos Hatzis, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2017 被引用: 718

  13. Functional significance of cholesterol metabolism in cancer: from threat to treatment

    著者: Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Jialin Li, Hang Xu, Yingjun Zhao, Xianjun Yu, Si Shi - Experimental & Molecular Medicine 2023 被引用: 201

  14. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells

    著者: Ye Zeng, Qifeng Zhuo, Qiangsheng Hu, Xiaowu Xu, Mengqi Liu, Zheng Zhang, Wenyan Xu, Wensheng Liu, Guixiong Fan, Yi Qin, Xianjun Yu, Shunrong Ji - Redox Biology 2020 被引用: 286

  15. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment

    著者: Chaoyi Zhang, Jin Xu, Rong Tang, Jianhui Yang, Wei Wang, Xianjun Yu, Si Shi - Journal of Hematology & Oncology 2023 被引用: 135

  16. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

    著者: Yunzhen Qian, Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Shengming Deng, Cheng He, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu - Journal of Hematology & Oncology 2020 被引用: 312

  17. Histone lactylation: from tumor lactate metabolism to epigenetic regulation

    著者: Xiaoning Yu, Jing Yang, Jin Xu, Haoqi Pan, Wei Wang, Xianjun Yu, Si Shi - International Journal of Biological Sciences 2024 被引用: 120

  18. The microbiota and microbiome in pancreatic cancer: more influential than expected

    著者: Miao-Yan Wei, Si Shi, Chen Liang, Qing-Cai Meng, Jie Hua, Yi-Yin Zhang, Jiang Liu, Bo Zhang, Jin Xu, Xianjun Yu - Molecular Cancer 2019 被引用: 260

  19. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma

    著者: Xiaomeng Liu, Rong Tang, Jin Xu, Zhen Tan, Chen Liang, Qingcai Meng, Yubin Lei, Jie Hua, Yiyin Zhang, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Si Shi - Gut 2023 被引用: 100

  20. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

    著者: Heng Zhu, Miaoyan Wei, Jin Xu, Jie Hua, Liang Chen, Qingcai Meng, Yiyin Zhang, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi - Molecular Cancer 2020 被引用: 253

  21. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications

    著者: Haifeng Hu, Ye Zeng, Yi Qin, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Shunrong Ji - Acta Pharmacologica Sinica 2021 被引用: 151

  22. Angiogenesis in pancreatic cancer: current research status and clinical implications

    著者: Shuo Li, Hua-Xiang Xu, Chun-Tao Wu, Wen-Quan Wang, Wei Jin, He-Li Gao, Hao Li, Shi-Rong Zhang, Jin-Zhi Xu, Zi-Hao Qi, Quan-Xing Ni, Xianjun Yu, Liang Liu - Angiogenesis 2018 被引用: 290

  23. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer

    著者: Qiangsheng Hu, Yi Qin, Shunrong Ji, Wenyan Xu, Wensheng Liu, Qiqing Sun, Zheng Zhang, Mengqi Liu, Quanxing Ni, Xianjun Yu, Xiaowu Xu - Cancer Letters 2019 被引用: 156

  24. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer

    著者: Wenxi Zhou, Xinli Chen, Yu Zhou, Si Shi, Chen Liang, Xianjun Yu, Hongyi Chen, Qin Guo, Yiwen Zhang, Peixin Liu, Chao Li, Yongchao Chu, Yifan Luo, Yu Wang, Zheng Zhou, Zhenhao Zhao, Qinjun Chen, Tao Sun, Chen Jiang - Biomaterials 2021 被引用: 81